Healthy Volunteers Clinical Trial
Official title:
Effect of a HIIT Program Compared to MICT on the Self-esteem, Basal Metabolic Rate and Muscle Mass in Women 18 to 44 Years Old With Overweight or Obesity, Over a Period of 8 Weeks: a Randomized Control Trial.
Overweight and obesity are a public health problem for society, reflected by an increase in
its prevalence worldwide, being more frequent in women and related to low levels of
self-esteem, accumulation of subcutaneous fat and internal organs, reduction of muscle mass
(MM) and basal metabolic rate (BMR). Women are more predisposed to present weight gain
because they are metabolically less efficient, have greater food intake, greater physical
inactivity, and genetic factors. The different methods of physical training used for weight
control are continuous training (CT) and the high-intensity interval training (HIIT). Both CT
and HIIT have shown benefits without finding superiority of any of these methods.
Nevertheless, there is a trend to the use HIIT programs, since they are more time-efficient
and supports their use to induce physiological and metabolic adaptations over time, since
this is a barrier to adherence to exercise programs. Overweight and obesity causes individual
alterations in body composition and exercise leads to increase in MM, increase in caloric
expenditure during the training session and increase in BMR due to the onset of muscle
growth, secondary to an increase in the activity of the mitochondrial enzymes (greater
mitochondrial biogenesis in the muscle), adaptations that could depend on the type of
exercise, its intensity and the volume of it, but it is not clear due to the lack of evidence
regarding this.
The primary objective of this study is to demonstrate that a HIIT program of short duration
in a real-world setting has a standardized mean difference (SMD) higher than 0.84 in the
improvement of self-esteem when comparing with a moderate-intensity continuous training
(MICT) in women 18 to 44 years with overweight and obesity and low self-esteem, during eight
weeks.
The secondary objective is to demonstrate that a low-volume HIIT in a real-world setting
improves MM in 2% compared with MICT during a period of eight weeks in women 18 to 44 years.
Fifty women with low self-esteem will be randomly assigned to one of two training programs
(MICT or HIIT) in a real-world setting. Both groups will perform three times a week for
eight-weeks on alternate days.
The women in each group will perform three workouts per week for a period of eight weeks. The
moderate-intensity continuous training group will perform a training session of 40 min
duration at an intensity between 65 and 75% of your HRmax. Women assigned to the group HIIT
will perform a training session of 22 minutes of duration by performing intervals of high
intensity between 90 and 95 % of the HRmax for 30 seconds in duration and with a recovery of
one minute training at moderate intensity is between 50 and 60 % of the HRmax, doing 15 loads
of 30 seconds at high intensity, with 60 seconds of recovery between loads at moderate
intensity. At the beginning of each training session, both groups will complete strength
exercises mainly including large muscle groups (hip, knees, and ankles) with Theraband® (blue
color ) for 3 sets of 15 repetitions.
All participants will be evaluated before initiating interventions and upon completion of the
training program, after eight weeks, self-esteem will be assessed using the Rosenberg
self-esteem scale, determination of anthropometric variables such as weight, height, waist
circumference, arterial pressure, body composition by bioimpedance and the basal metabolic
rate.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |